Analysis – Page 4
-
AnalysisFrom liability to D&O: The different aspects of environmental risk
No organisation – whatever their size or sector – is immune to increased environmental scrutiny Part of an environmental risk series supported by
-
AnalysisWhat are the business risks of investing in Russia?
As sanctions were imposed on Russia for its role in the Ukraine crisis, capital has flown out of the country and M&As have dwindled. With sanctions likely to remain in place for a while, should businesses stay away or will ignoring Russia as an investment destination prove a short-sighted strategy?
-
AnalysisGermany exempted from mandatory rebates for pharmaceutical companies
The European Commission found that the scheme pursues an objective of common interest
-
AnalysisAGCS creates cyber role to combat increasing threat
Insurer responds to rising client concerns with dedicated cyber role
-
AnalysisHealthcare in Africa improves amid Ebola outbreak
International SOS’ analysis reveals the world’s most dangerous locations concerning health risk
-
AnalysisDoes your insurance cover you for Ebola-related claims?
With the disease spreading further and further, corporate policyholders would be wise to assess their insurance coverage
-
AnalysisTop five dos and don'ts of managing corruption investigations
Control Risks crisis management experts on how to avoid damage to business continuity, reputation and share price resulting from a corruption investigation by a regulator
-
AnalysisQ&A: Ebola and the health implications for the EU
With the number of cases now having reached more than 8,000, the EU has issued a Q&A on the deadly virus
-
AnalysisCaptives: Self-managed or outsourced?
Flourishing interest from SMEs and a growing awareness of non-traditional risks spell good news for captive insurance
-
AnalysisACE addresses growing casualty exposures in Europe’s life science industry
Insurer aims to support life science firms in Continental Europe with an enhanced proposition that includes catastrophe management
-
AnalysisEbola outbreak could affect supply chains
Businesses need to consider in more detail the wider impact on their operations of outbreaks of infectious diseases
-
AnalysisAlvarez and Marsal appoint Teixeira as managing director
Former Willis practice leader Tom Teixeira has been appointed to expand the firm’s risk advisory and business resilience offerings
-
AnalysisManaging risk in food and drink
It falls to risk managers to ensure our sources of food and drink are kept safe and secure
-
AnalysisProfile: Stephen Cross – Aon Global Risk Consulting
Aon’s data and cyber expert Stephen Cross tells StrategicRISK about the firm’s journey into data research and innovation
-
AnalysisBIOTECHNOLOGY: “Risk-managing the early stages of biotech products is critical”
Biotechnology is booming, yet the neglect of effective risk management could have disastrous consequences for the public and for the industry as a whole
-
AnalysisHow global brands are dealing with China’s anti-monopoly dawn raids
Dawn raids have proved the anti-cartel authorities in China mean business when cracking down on international firms
-
AnalysisNanotechnology – the next big thing for insurers
Insurers are having to learn to keep pace with fast-moving scientific developments such as nanotechnology
-
AnalysisRisk leaders struggle to manage major risks, global survey finds
Top 10 risks for 2013 and 2016 also unveiled
-
AnalysisBribery Act – the calm before the storm
The Bribery Act 2010 came into force in sthe UK a year ago. The predicted deluge of prosecutions has yet to happen, but companies should ensure now that they have robust policies in place
-
AnalysisPharma industry is 'fraught' with uninsured risks
A changing regulatory landscape means that the drugs companies are increasingly at risk
